Warhound Secures $200 Million to Produce Genetically Optimized Canines

Two hundred million dollars in fresh capital has been allocated to a new venture named Warhound, which intends to produce genetically modified dogs for the United States armed forces. The funding round supports a project that combines biological engineering with advanced tactical equipment to create a new class of working animals for defense applications.

The initiative is a joint effort driven by Ben Lamm, a figure known for his work at Colossal Biosciences, and Palmer Luckey, the founder of Anduril. Lamm confirmed to Wired that the team has already started modifying the genetic material of cell samples harvested from a specific group of donor animals. These donors were selected from high-performing military, police, and first responder units across the country. The pool consists primarily of Belgian Malinois, with a smaller number of Labrador Retrievers and German Shepherds included in the initial batch.

The immediate scientific objective is to mitigate the risk of common hereditary health problems. By editing the genes of these cell samples, the team aims to reduce the likelihood of conditions such as hip dysplasia and specific types of cancer that often affect these breeds. Following the genetic modification, the plan is to clone the animals using the edited samples. Lamm indicated to TechCrunch that future iterations of the project could focus on enhancing physical traits, potentially making the dogs faster, more agile, or equipped with a sharper sense of smell.

Both founders bring significant experience to the table from the technology and defense sectors. Luckey, who previously founded Oculus VR and designed the Oculus Rift headset, leads Anduril, a defense technology firm. His company established a partnership with OpenAI in 2024 to develop artificial intelligence for the Pentagon and recently secured a contract with the US Army to build its next-generation battlefield intelligence system in collaboration with Palantir. Lamm’s Colossal Biosciences is recognized for its de-extinction projects, including efforts to revive the dire wolf and the woolly mammoth.

Within this partnership, Anduril’s primary responsibility is the hardware and software components rather than the biological engineering. The startup does not appear to be pursuing a cyborg model for the initial phase. Instead, Anduril will design the protective gear, including goggles, vests, and body armor, along with the software systems that control these tools to safeguard the animals during their duties.

The corporate structure reveals a distinct separation between the partners. Although Luckey is a partner in the business, neither he nor Anduril holds an equity stake in Warhound. Colossal Biosciences does possess equity in the startup, and Lamm occupies a seat on the board. The company is led by David Spirk, who most recently held a position at Palantir, serving as the chief executive officer.

Production of the first generation of these engineered dogs is scheduled for early 2027. Once born, the animals will undergo training for the same roles currently performed by traditional working dogs. These roles include bomb detection and assistance in search-and-rescue operations, ensuring the new dogs are ready for immediate deployment in the field.